
Cbz-B3A
CAS No. 1884710-81-9
Cbz-B3A ( —— )
产品货号. M33307 CAS No. 1884710-81-9
Cbz-B3A 是 mTORC1 转导的有效选择性抑制剂,与泛素1、2、4 结合,Cbz-B3A 还能抑制 eIF4E 结合蛋白的磷酸化。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1395 | 有现货 |
![]() ![]() |
5MG | ¥2140 | 有现货 |
![]() ![]() |
10MG | ¥3190 | 有现货 |
![]() ![]() |
25MG | ¥5067 | 有现货 |
![]() ![]() |
50MG | ¥6960 | 有现货 |
![]() ![]() |
100MG | ¥9333 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Cbz-B3A
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cbz-B3A 是 mTORC1 转导的有效选择性抑制剂,与泛素1、2、4 结合,Cbz-B3A 还能抑制 eIF4E 结合蛋白的磷酸化。
-
产品描述Cbz-B3A is a potent and selective inhibitor of mTORC1 signaling that appear to bind to ubiquilins 1, 2, and 4, and Cbz-B3A inhibits the phosphorylation of eIF4E-binding protein 1 (4EBP1).
-
体外实验Cbz-B3A slows cellular growth of some human leukemia cell lines, but is not cytotoxic.Cbz-B3A has a larger effect on the phosphorylation of 4EBP1 than p70S6k compared to repamycin. Cbz-B3A inhibits mTOR through Ubiquilins. Cbz-B3A decreases the incorporation of [35S]methionine/cysteine into protein in a dose-dependent manner, with maximal inhibition of 68% observed at 10 μM, and an EC50 of ~3 μM.
-
体内实验——
-
同义词——
-
通路PI3K/Akt/mTOR signaling
-
靶点mTOR
-
受体mTOR
-
研究领域——
-
适应症——
化学信息
-
CAS Number1884710-81-9
-
分子量706.87
-
分子式C35H58N6O9
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 20 mg/mL (28.29 mM; 超声加热助溶 )
-
SMILESC(=NCCC[C@@H](C(NCCCCCCNC(OCC1=CC=CC=C1)=O)=O)NC(OC(C)(C)C)=O)(NC(OC(C)(C)C)=O)NC(OC(C)(C)C)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Coffey RT, et al. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling. J Biol Chem. 2016 Mar 4;291(10):5221-33.?